Xue Li on access to biologics in the Asia-Pacific region
From The Lancet Regional Health in conversation with by The Lancet Group
June 20, 2025 · 20 min
About this episode
This episode discusses the inequity in access to biologics in the Asia-Pacific region, particularly in lower-and-middle-income countries.
This is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in Rheumatology in Western populations, but in many parts of Asia, especially lower-and-middle-income countries, there remains substantial inequity in access due to differences in availability and affordability. In this episode, we explore the factors that may have delayed the popularisation of biologics in Asia, any recent p...
People in this episode
Guest: Prof Xue Li
Topics covered
- biologics
- Rheumatology
- health equity
- Asia-Pacific
- treatment access
Keywords
- biologics
- Rheumatology
- health equity
- Asia-Pacific
- treatment access
- affordability
- availability
Mentioned in this episode
Organizations: The Lancet Rheumatology, The Lancet Regional Health - Western Pacific
Places: Asia-Pacific, Western populations, lower-and-middle-income countries
More episodes of The Lancet Regional Health in conversation with
- Kate Yoo and Neil Schluger on Tobacco Control in South Korea · June 2, 2026 · 22 min
- Kunchok Dorjee on Comprehensive tuberculosis screening and Preventive treatment in India · March 23, 2026 · 15 min
- TLRH-SEA Year in review 2025 · February 16, 2026 · 15 min
- Cuilin Zhang and Wei-Jun Jean Yeung · December 8, 2025 · 30 min
- David Skerrett-Byrne and Lee Ashton · December 8, 2025 · 20 min
- Peter Chan and Xi Xia on air pollution, physical activity and COPD in China · October 14, 2025 · 13 min
Explore listener stats, chart rankings, contacts and more on the The Lancet Regional Health in conversation with podcast page.